{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-22-011277","form_type":"8-K","ticker":"BCPC","cik":"0000009326","company_name":"BALCHEM CORP","filed_at":"2022-04-29T23:59:59+00:00","discovered_at":"2026-05-14T18:04:04.474103+00:00","generated_at":"2026-06-26T02:59:44.664953+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Balchem Q1 2022: Record sales $228.9M, GAAP EPS $0.89, adjusted EPS $1.03, all segments up double-digit","bullets":["Net sales $228.9M (+23.3% YoY); GAAP net earnings $28.9M (+23.6% YoY); diluted GAAP EPS $0.89.","Adjusted EPS $1.03 (vs $0.87 YoY); adjusted EBITDA $53.6M (+17.2% YoY).","All three segments (Human Nutrition, Animal Nutrition, Specialty Products) delivered double-digit sales growth.","Cash from operations $7.0M; free cash flow $(2.8)M for the quarter.","Released 2021 Sustainability Report; targets 25% reduction in emissions and water usage by 2030."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-22-011277","json":"https://secwatch.observer/filing/0001628280-22-011277.json","markdown":"https://secwatch.observer/filing/0001628280-22-011277.md","text":"https://secwatch.observer/filing/0001628280-22-011277.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/9326/000162828022011277/0001628280-22-011277-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/9326/000162828022011277/bcpc-20220429.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T02:59:44.664953+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}